ArticleBMC cancer2011

Cost-analysis of XELOX and FOLFOX4 for treatment of colorectal cancer to assist decision-making on reimbursement.

Vicki C Tse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.